The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).
 
Reena Parada Thomas
No Relationships to Disclose
 
Seema Nagpal
Consulting or Advisory Role - Nektar; Novartis; Novocure; Regeneron
Research Funding - Nektar
 
Michael Iv
No Relationships to Disclose
 
Scott G. Soltys
Consulting or Advisory Role - Nektar
 
Zachary Corbin
No Relationships to Disclose
 
Linda Wei Xu
No Relationships to Disclose
 
Cathy Kahn Recht
Honoraria - Nektar (I)
Consulting or Advisory Role - Nektar (I)
Research Funding - Nektar (I); Sanofi (I)
Travel, Accommodations, Expenses - Nektar (I)
 
Sophie Bertrand
Research Funding - Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); MedImmune (Inst); Nektar (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - ImmunoCellular Therapeutics; Tocagen
 
Vani Jain
Research Funding - Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); MedImmune (Inst); Nektar (Inst)
 
Brenda Acevedo
Research Funding - Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Nektar (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Vascular Biogenics
 
Martin Brown
Consulting or Advisory Role - Regeneron
Research Funding - NuvOx Pharma
Patents, Royalties, Other Intellectual Property - patent pending
 
Lawrence David Recht
Consulting or Advisory Role - Agenus; Sanofi
Research Funding - Berg Pharma; Nektar; Sanofi
Other Relationship - GE Healthcare